Loading Please wait, logging in.
Join ALFA Member Login RSS Feed
Tagline Image
Bookmark and Share  

Antipsychotics Beneficial For Some Individuals With Alzheimer’s

A new study suggests that people with Alzheimer’s on the drug risperidone, an antipsychotic drug often prescribed as the brand name Risperdal, may be better off continuing to take the drug if they have not experienced negative side effects.

Because of the potential side effects, risperidone is only recommended to be prescribed for three to six months. After that point, a written explanation is required to continue the drug. A study, published in the New England Journal of Medicine and funded by the National Institutes of Health, investigated the effects of discontinuing the medication among individuals who had seen improvements as a result of the drug. Researchers prescribed risperidone to individuals with Alzheimer’s disease who showed signs of agitation and aggression. After 16 weeks, researchers put half of the individuals who did well on the drug on a placebo. The other half continued the treatment. The study found that those on the placebo were twice as likely to have their symptoms return. The rate of side effects and death were equal among the two groups.

Researchers warned that antipsychotics can carry the risk of serious side effects and should not be used on all individuals with Alzheimer’s disease, but discontinuing medication that has achieved benefits is not always the right choice. "One must be cautious about discontinuing the medication,” said study author Dr. D.P. Devanand, director of the division of geriatric psychiatry at Columbia Psychiatry and the New York State Psychiatric Institute in New York City.  “If a person does well on it and there are not too many side effects, maybe they should stay on it for a while and be monitored closely."

For more information, read the article: Some With Alzheimer's Better Off Staying on Antipsychotics: Study  Or, read the full study: Relapse Risk after Discontinuation of Risperidone in Alzheimer's Disease.

 
Suggested Articles:

5/27/2015
Falls Prevention, Managed Risk
More than one-third of people age 65 and older fall each year and those who fall once are two to three times more likely to fall again, according to t...
5/27/2015
Falls Prevention, Managed Risk
Direct Supply Inc. carrying Medical Protection Technologies’ next-generation Fall-Safe Hip Protectors. Hip fractures, which occur in the U.S. about e...
5/20/2015
ALFA Conference & Expo, Business Planning, CEO, cheatsheet, Clinical Quality and Quality Care Delivery, Consumer Intelligence, Strategy
More Americans proactively will seek to reside in senior living communities, and the industry has a role to play in ensuring that consumers will be fi...
5/20/2015
The National Institutes of Health recently released recommendations providing a framework for an Alzheimer’s disease research agenda that was develope...
5/13/2015
End of Life, Federal Agency Activity, Managed Risk, Medication Management, Memory Care Best Practices and Research
Federal and state policies generally encourage the use of available generic drug products as do private payers such as insurers and others, which is w...
5/13/2015
Accessiblity Issues, Consumer Intelligence, Disabilities, Falls Prevention, Managed Risk
Older adults using mobility devices such as canes, wheelchairs and scooters do not fall more than those who do not use them, according to a new Nation...
5/13/2015
The National Institutes of Health is encouraging people to volunteer for clinical trials that look for ways to prevent, slow and treat Alzheimer’s dis...
5/7/2015
Formalizing standards around memory care is the top priority for the newly formed ALFA Memory Care Roundtable. The group, which met in person for the ...
4/28/2015
The average American is now spending about 20 years in retirement, noted Consumer Finance Protection Board Director Richard Cordray in remarks at a Wh...
4/28/2015
The Bipartisan Policy Center recently released a white paper recommending creating standardized quality performance measures that are user-friendly, m...
   
10/23/2012


Additional Resources